Recently, however, we showed the clinical relevance of SGLT2 in resected lung adenocarcinoma, and the expression of SGLT2 was more frequently detected in advanced-stage and more aggressive adenocarcinomas with aggressive biological behavior than in their counterparts. The gene discussed is SLC5A2; the disease is adenocarcinoma.